Start your research confidently with a reliable source of high-quality induced pluripotent stem cells (iPSCs) from the SCTi005-A cell line. SCTi005-A is derived from healthy female donor peripheral blood mononuclear cells (PBMCs), making it suitable for various applications, such as for use as an unaffected control, gene editing, or downstream differentiation to lineage-specific cell types and organoids.
To ensure optimal product performance and reproducibility, SCTi005-A is manufactured using extensive quality control procedures in a culture system consisting of mTeSR™ Plus, Corning® Matrigel® hESC-Qualified Matrix, and ReLeSR™. SCTi005-A is karyotypically stable, demonstrates trilineage differentiation potential, expresses undifferentiated cell markers, and was reprogrammed using a non-integrating reprogramming technology. Registration with hPSCreg® ensures ethical and biological conformity based on community standards.
Choose TeSR™ and STEMdiff™ cell culture media products to establish a complete workflow for your cell culture system. For alternative genotypes for your iPSC control lines, see all of our high-quality, healthy control human iPSC lines, female and male.
This research-use-only (RUO) product has been consented for both academic and commercial use. Blood samples are ethically sourced using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. For donor details and cell quality characterization of the source cell banks, refer to the data figures on this page. For additional details, refer to the lot-specific Certificate of Analysis and Frequently Asked Questions about induced pluripotent stem cell lines.
Whole exome and whole genome sequence data files are available upon request. Please contact us for pricing.
Certain products are only available in select territories. Please contact your sales representative or Product & Scientific Support at
[email protected] for further information.
